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The choroid plexus epithelium constitutes the structural basis of the blood-cerebrospinal ﬂuid barrier. Since the cytokine TNFα
is markedly increased during inﬂammatory diseases in the blood and the central nervous system, we investigated by which
mechanisms TNFα induces barrier alteration in porcine choroid plexus epithelial cells. We found a dose-dependent decrease of
transepithelial electrical resistance, increase of paracellular inulin-ﬂux, and induction of histone-associated DNA fragmentation
andcaspase-3activationafterTNFαstimulation.Thisresponsewasstronglyaggravatedbytheadditionofcycloheximideandcould
partially be inhibited by the NF-κB inhibitor CAPE, but most eﬀectively by the pan-caspase-inhibitor zVAD-fmk and not by the
JNK inhibitor SP600125. Partial loss of cell viability could also be attenuated by CAPE. Immunostaining showed cell condensation
and nuclear binding of high-mobility group box 1 protein as a sign of apoptosis after TNFα stimulation. Taken together our
ﬁndings indicate that TNFα compromises PCPEC barrier function by caspase and NF-κB dependent mechanisms.
1.Introduction
In the mammalian brain the cerebrospinal ﬂuid (CSF) is
produced by the choroid plexus (CP), which not only
regulates homeostasis in the central nervous system (CNS),
but also participates in neurohumoral brain modulation
as well as neuroimmune interaction [1, 2]. The CP is a
highly perfused organ; the endothelial and epithelial cells
of the CP separate the blood from the CSF. Whereas the
endothelial cells are fenestrated, the epithelial cells of the CP
are closely connected to each other by tight junctions (TJs)
and constitute the structural basis of the blood-CSF barrier.
The barrier function of the TJs can be subject to modulation
and thereby regulates the entry of physiologically important
substances as well as immune modulatory components and
cells during inﬂammatory events [3, 4].
Over the course of neuroinﬂammatory diseases, includ-
ing meningitis after infection with bacterial pathogens,
the composition of the CSF undergoes signiﬁcant changes
including the accumulation of certain cytokines [5, 6].
In agreement, expression of the proinﬂammatory cytokine
TNFα is markedly increased in porcine choroid plexus
epithelial cells after infection with the gram-positive bac-
terium Streptococcus suis [7]. Subsequently, injury of the
CP due to inﬂammatory responses may cause further
impairment of the blood-CSF barrier and allow enhanced
entry of immune system cells into the CNS [1, 2].
TNFα exhibits pleiotropic functions and is involved in
several cellular processes including inﬂammation, immune
responses, cell death and cell proliferation. TNFα mediates
its function via the two TNF receptors (TNFRs). TNFR1 is
expressedonallcells,whereasTNFR2isfoundonendothelial2 Journal of Biomedicine and Biotechnology
cells and cells of the immune system [8–10]. Signalling
through TNFR ligation can initiate (i) programmed cell
death (apoptosis), (ii) antiapoptotic and proinﬂammatory
responses through NF-κB, and (iii) activation of the mitogen
activated protein kinase (MAPK) JNK signalling pathway
[11]. These signal transduction mechanisms are tightly
interconnected with each other through a complex network
and their modulation allows to shifting the cellular state
either towards survival or cell death [11, 12].
Employing an in vitro model of the blood-CSF barrier
we have previously shown that cell death by apoptosis and
necrosis participates in barrier loss of porcine choroid plexus
epithelialcells(PCPEC)afterinfectionwithStreptococcussuis
[13]. Furthermore, treatment of PCPEC with TNFα caused
distinct inﬂammatory responses including tight junction
and actin cytoskeleton disorganisation, the upregulation of
cell adhesion molecules and an increased activity of matrix
metalloproteases in PCPEC supernatants [14]. We now
investigated in detail the involvement of apoptotic and non-
apoptotic mechanisms in the modulation of PCPEC barrier
function in response to treatment with TNFα.
2.MaterialsandMethods
2.1. Preparation and Cultivation of Choroid Plexus Epithelial
Cells. Epithelial cells from porcine choroid plexus were
obtained by a modiﬁed preparation as basically described
by Gath et al. [15]. Brieﬂy, brains from freshly slaughtered
pigs were dissected and the choroid plexus tissue from
the lateral and the fourth ventricles was removed and
treated withconsecutive cold and warm trypsinisation (0.2%
solution, Biochrom, Berlin, Germany, 45 minutes at 4◦C,
20 minutes at 37
◦C ) .T h ec e l l sw e r ec e n t r i f u g e da t2 0
× g for 10 minutes and resuspended in DMEM/HAM’s
F12 1 : 1 supplemented with 4mM L-glutamine, 10% heat
inactivated fetal calf serum, 5μg/mL insuline, and penicillin
(100U/mL)/streptomycin (100μg/mL). In order to suppress
the growth of contaminating ﬁbroblast like cells, 20μMo f
cytosine-arabinosidewereadded.Thecellswereeitherplated
on 6-, 24-, or 96-well plates (Falcon, BD, Le Pont De Claix,
France) using a seeding density of 50cm2/g wet weight
of choroid plexus tissue or on laminin coated permeable
Transwellﬁltermembranes(Costar,Cambridge,USA)witha
diameter of 12mm. Upon conﬂuence, PCPEC had a seeding
density of approximately 1 × 105 cells/cm2. After reaching
conﬂuence they were cultivated in serum-free medium and
wereused for the experiments 3–5 days later. Allexperiments
were performed with cells that had been cultured in SFM for
at least 3-4 days and exhibited high TEER values of at least
1000Ohm × cm2 on Transwell ﬁlter membranes.
2.2. Stimulation of Cells and Inhibition Studies. To investi-
gate PCPEC barrier function recombinant porcine TNFα
(R&D systems, Minneapolis, USA) was applied at 1, 10,
or100ng/mL apically or basolaterally as indicated in the
respective experiments. The protein synthesis inhibitor
Cycloheximide was used at a concentration of 1μg/mL,
the NF-κB inhibitor caﬀeic acid phenethyl ester (CAPE)
at 5μM, the JNK-inhibitor SP600125 at 10μM( a l lp r o d -
ucts were purchased from Merck, Darmstadt, Germany),
and the pan-caspase-inhibitor N-benzyloxycarbonyl-Val-
Ala-Asp-ﬂuoromethyl-ketone (zVAD-fmk; ICN, Heidelberg,
Germany) was used at 10μM. PCPECs were preincubated
with inhibitors for 2 hours prior to the experiment. Stau-
rosporine (Calbiochem, Germany) was added at a concen-
tration of 1μM.
2.3. Measurement of Transepithelial Electrical Resistance
(TEER). Conﬂuence of the PCPEC monolayers and barrier
properties were documented by measuring TEER using an
epithelial tissue voltohmmeter (EVOM, World Precision
Instruments, Sarasota, FL, USA) and the STX-2 electrode
system. PCPEC inverted cultures were used when TEER
values reached more than 1000Ω × cm2.I nT N F α assays
TEER was monitored over a range of 48 hours. Resistance
values of cells in medium alone were used as negative
control values and stayed above 1000Ω × cm2 during all
experiments.
2.4. Determination of Paracellular Permeability. TEER
changes reﬂect variation in tight junction integrity, although
they may also indicate changes in permeability at the
membrane level. As an independent measure of paracellular
permeability of choroid plexus epithelium monolayers,
we examined the passage of a membrane-impermeable
water-soluble compound FITC-inulin (Sigma, Deisenhofen,
Germany) across cell monolayers. The FITC-inulin ﬂux was
determined by measuring its paracellular passage from the
apical to the basolateral compartment of the Transwell ﬁlter.
FITC-inulin was dissolved in culture medium. The tracer
solution (100μg/mL) was loaded into the apical Transwell
ﬁlter compartment during the incubation period. After
stimulation with TNFα medium samples were collected
from the basolateral Transwell compartment over a range of
poststimulation intervals of 24 hours and the ﬂuorescence
was determined by measurement in a Tecan Inﬁnite M200
Multiwell reader (Tecan, Switzerland).
2.5. DNA Fragmentation Assay. For identiﬁcation of apop-
totic cells an ELISA was used measuring intracellular
histone-associated DNA fragments according to the man-
u f a c t u r e r ’ sp r o t o c o l( C e l lD e a t hD e t e c t i o nE L I S AP L U S ;
Roche Molecular Biochemicals, Mannheim, Germany). This
quantitative sandwich enzyme immunoassay speciﬁcally
detects the histone region of mono- and oligonucleosomes
that are released during apoptosis. PCPECs were stimulated
with TNFα for 8 hours, 24 hours, and 48 hours with
or without the indicated inhibitors. After stimulation the
cells were lysed and the supernatant containing the nuclear
derived histone-associated DNA fragments was used for
ELISA. Absorption was monitored by reading the plate
at 405nm using a Flow Titertek Multiscan PLUS (ICN,
Heidelberg, Germany). Apoptosis was measured in duplicate
from each group and expressed as the absorbance (optical
density) of the experimental cell lysates after 30 minutes of
development.Journal of Biomedicine and Biotechnology 3
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Figure 1: Apical and basolateral TNFα stimulations induce an equal eﬀect on PCPEC barrier function. PCPECs grown on Transwell ﬁlters
were stimulated apically (a) or basolaterally (b) with diﬀerent doses of TNFα (1, 10, 100ng/mL) with or without the protein synthesis
inhibitor cycloheximide (1μg/mL). Eﬀects on barrier function by measuring Transepithelial electrical resistance (TEER) were determined at
24 hours. The TEER results are expressed as a percentage of baseline. The data shown are mean ± SEM of four independent experiments,
each performed in duplicate.
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Figure 2: TNFα-induced decrease of TEER in PCPEC is caspase- and NF-κB-dependent. Eﬀects of the pan-caspase inhibitor zVAD-fmk
(10μM), the NF-κB inhibitor CAPE (5μM), and the JNK-inhibitor SP600125 (10μM) on TNFα-induced decrease of TEER in PCPEC were
determined at 24 hours. PCPECs were stimulated apically with TNFα (100ng/mL) with (b) or without (a) cycloheximide (1μg/mL). The
TEER results are expressed as a percentage of baseline. The data shown are mean ± SEM of four independent experiments, each performed
in duplicate. #P-value of <.0 5c o m p a r e dt oT N F α stimulated PCPEC without inhibitor; ∗P-value of <. 05 compared to unstimulated PCPEC.
2.6. Assessment of Caspase Activity. Caspase activity was
measured using a ﬂuorometric assay as described in [16].
In brief, of TNFα stimulated cells PCPECs were ﬁrst lysed
in 75μLl y s i sb u ﬀer to collect their intracellular contents.
For the ﬂuorometric cleavage assay, 50μg of the cell extracts
were directly dissolved in 200μLs u b s t r a t eb u ﬀer (50mM
HEPES pH 7.3, 100mM NaCl, 10% sucrose, 0.1% CHAPS,
10mM DTT) supplemented with 50μM of the ﬂuorogenic
substratesAc-DEVD-AMCforcaspase-3,Ac-IETD-AMCfor
caspase-8, or Ac-LEHD-AMC for caspase-9 (MP Biomed-
icals, Eschwege, Germany). The release of aminomethyl-
coumarin was measured ﬂuorometrically over 5 hours at
37
◦C using a Lambda Fluro 320 Plus ﬂuorometer (Biotek,
Bad Friedrichsall, Germany; excitation: 360nm, emission:
475nm). The catalytic activities are expressed as ﬂuorogenic
units (FU)/min.
2.7. Measurement of Cell Viability. Vitality of the cells
was measured using Life/Dead assay (Molecular Probes,
G¨ ottingen, Germany). The viability kit contains two com-
ponents. Calcein penetrates the membrane of vital cells,
and esterases in the cytoplasm render it ﬂuorescent (green).
Ethidium homodimer is not able to penetrate intact cell
membranes but adheres to nucleic acids of damaged cells
(redﬂuorescentcells).Forcellstaininga2μMsolutionethid-
ium homodimer and a 4μM solution of calcein-AM were
used. The results were photodocumented by ﬂuorescence
microscopy.
2.8. Measurement of Lactate Dehydrogenase (LDH) Activity.
Cell integrity was determined after treatment by measuring
the lactate dehydrogenase activity in the culture supernatant
using a commercially available kit (Roche, Mannheim,4 Journal of Biomedicine and Biotechnology
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Figure 3:TNFα-inducedincreaseofparacellularinulinﬂuxinPCPECiscaspase-andNF-κB-dependent.Eﬀectsofthepan-caspaseinhibitor
zVAD (10μM), the NF-κB inhibitor CAPE (5μM), and the JNK-inhibitor SP600125 (10μM) on TNFα-induced increase of paracellular
FITC-inulin ﬂux in PCPECs were determined at 24 hours. The FITC-inulin ﬂux was measured in the apical-to-basolateral direction with
or without stimulation and is expressed as percentage of tracer in the basolateral compartment. PCPEC were stimulated apically with
TNFα (100ng/mL) with (b) or without (a) cycloheximide (1μg/mL). The data shown are mean ± SEM of four independent experiments,
each performed in duplicate. #P-value of <.05 compared to TNFα stimulated PCPEC without inhibitor; ∗P-value of <. 05 compared to
unstimulated PCPEC.
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Figure 4: TNFα induces DNA-fragmentation in PCPEC. TNFα-induced apoptosis was determined by ELISA measuring the number of
cellular histone-associated DNA fragments. (a) The concentration of histone-associated DNA-fragments was determined 8 hours, 24 hours,
and 48 hours following apical stimulation with TNFα. PCPEC were stimulated apically with TNFα (100ng/mL) alone or costimulated with
cycloheximide (1μg/mL). Thedata shown are mean ± SEM of three independent experiments, each performed in duplicate. (b) Appearance
of histone-associated DNA fragments after 24 hours treatment with diﬀerent doses of TNFα (1, 10, 100ng/mL) in presence or absence of
cycloheximide (1μg/mL). A representative experiment out of three performed in duplicates is shown. OD, optical density.
Germany). LDH release into the medium was expressed as
the percentage of total LDH (i.e., LDH present in medium
and the cells).
2.9. Immuncytochemistry. Cells were plated and observed
in 6 wells. After stimulation with TNFα cells were washed
with HBSS/HEPES, ﬁxed with PBS/4% paraformaldehyde,
and permeabilized with PBS/0.5% Triton X-100. HMGB1
was detected by indirect immunoﬂuorescence using an anti-
HMGB1 antibody (BD Biosiences, Heidelberg, Germany) at
1 : 500 dilution for 12 hours at 4◦C and chicken anti-rabbit
antibody coupled to Alexa ﬂuor 594 (Molecular Probes,
Oregon, USA) at 1 : 250 dilution for 15 minutes at 4◦C.
Cells were also stained with 4 -6-diamidino-2-phenylindole
dihydrochloride (DAPI, 100ng/mL) dilution for 5 minutes
at room temperature and observed on an Axioplan 2
microscope with ﬁlter set 2 and 31 (Carl Zeiss, G¨ ottingen,
Germany).
2.10. Data Analysis. Data are presented as means ± SEM.
The statistical signiﬁcance between the groups comparisons
wasdeterminedbyStudent’st-test.Aprobabilityvalueofless
than.05 was considered statistically signiﬁcant.
3. Results
To investigate the inﬂuence of TNFα on PCPEC barrier
function we treated PCPEC monolayers grown on Transwell
ﬁlters with TNFα for 24 hours and measured the transep-
ithelial electrical resistance (TEER). Addition of increasingJournal of Biomedicine and Biotechnology 5
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Figure 5: Caspase inhibition prevents TNFα-induced DNA fragmentation. Inﬂuences of inhibitors of caspases, NF-κB, and JNK were
analyzed in respect to TNFα-induced PCPEC DNA fragmentation. PCPECs were stimulated apically with TNFα (100ng/mL) with (b)
or without (a) cycloheximide (1μg/mL). Cells were additionally preincubated with zVAD (10μM), CAPE (5μM) or SP600125 (10μM) for
2 hours as indicated. Results of these experiments were measured as an optical density (OD). The data shown are mean ± SEM of three
independent experiments, each performed in duplicate; #P-value of <. 05 compared to treated PCPEC without inhibitor.
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Figure 6: TNFα strongly activates caspase-3 in PCPEC. Caspase-3 activation (given as change of ﬂuorescence per minute in arbitrary units
(ΔFU/min.))wasmeasuredinPCPECafterstimulationwithTNFα(100ng/mL)for24hourswithandwithoutzVAD(10μM),CAPE(5μM)
or SP600125 (10μM) preincubation for 2 hours (a), and coincubation with cycloheximide (CHX) (1μg/mL) (b) and unstimulated control.
The data shown are mean ± SEM of three independent experiments (n = 3), each performed in duplicates. ∗P-value of <. 05 compared to
unstimulated PCPEC; #P-value of <.0 5c o m p a r e dt oT N F α ± CHX stimulated PCPEC without inhibitor.
amounts of TNFα to the apical (Figure 1(a)) or basolateral
(Figure 1(b)) side of PCPEC caused a dose-dependent
drop of the TEER under both conditions at 10ng/mL and
100ng/mL of TNFα,b u tn o ta t1n g / m L .S u p r e s s i o no fp r o -
tein synthesis by cotreatment with the translation elongation
inhibitor cycloheximide (CHX) leads to a strong decrease of
the TEER under all conditions investigated. Treatment with
CHX alone also leads to a signiﬁcant decrease of the TEER
(Figures 1(a) and 1(b)). Since apical and basolateral TNFα
application with or without CHX caused similar eﬀects
on PCPEC barrier function further experiments were only
performed after apical stimulation of PCPEC.
TNFα signaling is mediated by TNFRs and involves
induction of apoptosis as well as activation of NF-κBa n d
JNK signaling pathways [9–11]. To dissect the contribution
of the three above-mentioned pathways to modulation
of PCPEC barrier function by apically added TNFα,w e
preincubated PCPEC grown on Transwell ﬁlters with speciﬁc
inhibitors prior to treatment with TNFα in absence or
presence of CHX. To inhibit apoptosis, the cells were
preincubated for 2 hours with 10μM of the pan-caspase
inhibitor zVAD-fmk. For attenuation of either NF-κBo r
JNK signaling, a 2 hours preincubation step with a low
(5μM) concentration of the NF-κB inhibitor caﬀeic acid
phenethyl ester (CAPE) or with 10μM of the JNK inhibitor
SP600125, respectively, was conducted. As can be seen in
Figure 2(a) pretreatment with all three inhibitors caused a
slight but signiﬁcant attenuation of the TEER drop caused
by subsequent treatment with TNFα alone, whereas none of
the inhibitors by itself caused a signiﬁcant change in TEER.
When cells where stimulated with a combination of TNFα
and CHX, pretreatment with both zVAD-fmk and CAPE
signiﬁcantly inhibited the observed strong decrease in TEER,
with zVAD-fmk being a more potent inhibitor then CAPE
(Figure2(b)).UndertheseconditionsSP600125exhibitedno
signiﬁcant eﬀect (Figure 2(b)).6 Journal of Biomedicine and Biotechnology
In addition to the TEER values the paracellular inulin
ﬂux levels can be regarded as a measure for the barrier
function of epithelia. Determination of the inulin ﬂux
revealed that apical addition of TNFα alone to the PCPEC
caused a slight but signiﬁcant increase in permeability
(Figure 3(a)). In contrast, coincubation of the PCPEC with
TNFα and CHX leads to a strong increase in inulin ﬂux (Fig-
ure 3(b)). Under both conditions preincubation with zVAD-
fmk and CAPE signiﬁcantly attenuated the gain in inulin-
ﬂux, although zVAD-fmk demonstrated a stronger eﬀect
when PCPEC were activated with TNFα alone. Pretreatment
with the JNK inhibitor SP600125 did not reveal an eﬀect
on permeability under any of the conditions investigated
(Figure 3).
TNFα signal transduction via TNFRs is known to induce
death receptor mediated apoptotic pathways [11]. One of the
hallmarksofapoptosisistheappearanceofoligonucleosomal
DNA fragmentation caused by the caspase-activated DNA
nuclease, CAD [17, 18]. To investigate the level of apoptotic
cell death in PCPEC after apical treatment with TNFα in the
presence or absence of CHX we measured the appearance
of cytoplasmic histone-associated DNA fragments by ELISA.
Addition of TNFα alone resulted in a slight but signiﬁcant
increase in the apoptosis after 24 hours and 48 hours. In
contrast,coincubationofPCPECwithTNFαandCHXleads.
to a strong induction of programmed cell death already after
8 hours, which further increased after 24 hours and 48 hours
(Figure 4(a)). Treatment of PCPEC with diﬀerent doses of
TNFα (1, 10, 100ng/mL) for 24 hours caused only low levels
of cell death in absence of CHX. In contrast signiﬁcant
amounts of apoptosis were observed when PCPEC were
preincubated with CHX (Figure 4(b)). Levels of apoptosis
correlated to some extend with the loss of PCPEC barrier
function after treatment with TNFα in presence and absence
of CHX.
Additionally to the induction of apoptosis, TNFα acti-
vates signalling by NF-κB and JNK, which are both known
to contribute to inhibition of apoptosis due to the activation
of antiapoptotic gene expression [11]. Therefore, we next
analyzed the eﬀect of zVAD-fmk, CAPE, and SP600125 on
the appearance of oligonucleosomal DNA fragmentation
in PCPEC. Inhibition of caspases by zVAD-fmk attenuated
DNA fragmentation of PCPEC treated apically with TNFα
in the absence (Figure 5(a)) or presence (Figure 5(b))o f
CHX. In contrast, CAPE and SP600125 had no inhibitory
eﬀect under all conditions analysed (Figure 5). SP600125 did
even lead to a slight increase in DNA fragmentation when
compared to TNFα alone (Figure 5(a)). The three inhibitors
zVAD, CAPE and SP600125 alone had no eﬀect on DNA
fragmentation (data not shown). To evaluate apoptosis in
PCPEC in more detail we measured activation of caspase-
3 by a ﬂuorometric assay (Figure 6). Noteworthy, active
caspase-3 levels in cells treated with TNFα for 24 hours were
similarinabsence(Figure6(a))andpresence(Figure6(b))of
cotreatment with CHX. In agreement with the appearance of
DNA fragmentation, of the three inhibitors only zVAD-fmk
was able to reduce the level of caspase-3 activation. Again,
preincubation with SP600125 might cause rather a slight
increase in activation of caspase-3 in cells treated with TNFα
alone. zVAD-fmk, CAPE or SP600125 did not cause caspase-
3a c t i v a t i o ni na b s e n c eo fT N F α treatment (Figure 6(a)).
Treatment of cells with cytotoxic stimuli can result in
both apoptosis and necrosis. In vivo, apoptotic cells are
removed in a regulated manner allowing a minimum of
inﬂammatory responses. In contrast, necrosis is character-
ized by the release of intracellular components leading to a
proinﬂammatory response in surrounding tissues [19, 20].
To analyze the cytotoxic eﬀects of TNFα on PCPEC in more
detail, we measured the release of lactate dehydrogenase
(LDH), which is more closely associated with necrosis than
with apoptosis. TNFα alone caused a slight but signiﬁcant
LDH-release, which could only be attenuated by CAPE,
but not by zVAD-fmk or SP600125 (Figure 7(a)). When
PCPEC were treated with the combination of TNFα and
CHX a stronger LDH-release was observed. This release
was inhibited by both zVAD-fmk and CAPE (Figure 7(b)).
Treatment of PCPEC with zVAD-fmk, CAPE or SP600125
(Figure 7(a)) or with CHX (Figure 7(b)) alone had no
cytotoxic eﬀect.
The high mobility group 1 (HMGB1) protein is known
to be associated with condensed chromatin or to be released
from cells undergoing either apoptosis or necrosis, respec-
tively,[21].PCPECtreatedwithTNFαinpresenceorabsence
ofCHXwerestainedwithDAPIandanalyzedbyimmunoﬂu-
orescence with an antibody against HMGB1. Apoptotic cells
resulting from the diﬀerent treatments contained HMGB1,
conﬁrming programmed cell death caused by either TNFα
or TNFα in combination with CHX. Treatment of PCPEC
with staurosporine was performed as a positive control for
apoptosis. Cotreatment of PCPEC with TNFα and CHX
as well as addition of staurosporine produced also cells
with their HMGB1 released indicative of post-apoptotic
necrosis (Figure 8(b)). Increased amounts of dead cells
after incubation with the combination of TNFα and CHX
compared to treatment with TNFα alone were conﬁrmed by
a Live/Dead assay (Figure 8(a)).
4. Discussion
The participation of proinﬂammatory cytokines in the
pathophysiology of inﬂammatory CNS disease as bacterial
meningitis is well recognized. Such cytokines have been
implicated in epithelial barrier dysfunction [22, 23]a n d
in inducing epithelial cell apoptosis [24]. Our study was
designed to provide a detailed insight into the mechanism(s)
by which proinﬂammatory cytokines like TNFα compromise
PCPEC barrier function, and whether or not these are
causally linked to apoptosis. Signiﬁcant amount of TNFα
(45ng/mL) has been observed in the CSF of rabbits with
experimental meningitis caused by Haemophilus inﬂuenzae
type b lipooligosaccharide [25]. Additionally, concentrations
reaching up to 40ng/mL (mean ∼15ng/mL) have been
described in serum for a porcine model of meningococcal
shock [26].
The epithelial cells of the choroid plexus constitute
the structural basis of the blood-CSF barrier and have
been shown to respond to inﬂammatory challenge by theJournal of Biomedicine and Biotechnology 7
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Figure 7: Inhibition of NF-kB induction attenuates PCPEC cytotoxicity. Cytotoxicity in the presence of TNFα(100ng/mL) ±cycloheximide
(CHX)(1μg/mL)((a)and(b))for24hours,wasdetectedbymeasuringLDHactivityinthesupernatant.Cytotoxicityinhibitionexperiments
in PCPEC cells were performed after preincubation with zVAD-fmk (10μM), CAPE (5μM) or SP600125 (10μM) for 2-hour. The data are
expressed as the percentages of cytotoxicity in treated wells compared with cytotoxicity in control wells with PCPEC alone. The data shown
are mean ± SEM of three independent experiments, each performed in duplicate. ∗P-value of <. 05 compared to unstimulated PCPEC;
#P-value of <.0 5c o m p a r e dt oT N F α ± CHX stimulated PCPEC without inhibitor.
pleiotropic cytokine TNFα in an in vitro model employing
primary porcine choroid plexus epithelial cells. During these
studies TNFα was shown to alter tight junction function in
part via matrix-metalloproteases [14]. Interestingly, the gene
encoding for TNFα, among other inﬂammatory response
genes, is upregulated in the same cellular system after
infection with the gram-positive bacterium Streptococcus
suis.I n f e c t i o nw i t hS. suis aﬀects the barrier function of the
PCPEC in part by inducing cell death of PCPEC by apoptotic
and necrotic mechanisms [7, 13].
TNFα is known to exert its functions mainly via two
TNFRs, TNFR1 and TNFR2 [8–10]. Although to our
knowledge the distribution of TNFRs in the porcine brain
has not been investigated, data from an in vivo rat model
have indicated that in the choroid plexus TNFR1 is basally
expressed and upregulated after challenge with lipopolysac-
charide (LPS) or TNFα, whereas low TNFR2 expression
could only be detected after LPS or TNFα treatment [27].
We tested several antibodies against TNFR1 and TNFR2,
but none of them recognized porcine TNFRs and therefore
we could neither determine potential inhibitory eﬀects (data
not shown). TNFα induces distinct downstream regulatory
pathways, notably TNFR-mediated apoptosis and induction
of the NF-κB and JNK signaling pathways [11].
In the present study we investigated the downstream
eﬀects contributing to choroid plexus epithelial cell barrier
loss caused by TNFα in further detail. Treatment of PCPEC
with TNFα for 24 hours caused low levels of apoptosis as
evidenced by DNA fragmentation, chromatin condensation
and activation of caspase-3, which could be overcome by
the addition of zVAD-fmk. Under the same conditions a
signiﬁcant drop of the transepithelial membrane potential
concomitant with an increase in paracellular permeability
occurred indicating an impairment of barrier function. In
HT-29/B6 epithelial cells leaks in epithelial barrier due
to single-cell apoptosis, particularly following incubation
with TNFα,h a v eb e e nr e p o r t e d[ 24]. However, inhibition
of TNFα-induced pulmonary epithelial cell apoptosis only
partially restored barrier function, which underscores the
complexity of the mechanisms that regulate the biological
response to this cytokine in inﬂammatory injury cascades. In
our experiments, also a signiﬁcant LDH release, which could
be attenuated by the NF-κB inhibitor CAPE but not zVAD-
fmk, was observed pointing to additional necrotic events.
However, even pretreatment with CAPE or zVAD-fmk could
not completely inhibit loss of PCPEC barrier function. These
data support the hypothesis that not only cell death by
apoptosis and necrosis, but also cell death independent
eﬀects contribute to blood-CSF barrier breakdown during
inﬂammation in the CNS [13, 14, 28–31].
Hallmarks of apoptosis (DNA fragmentation, chromatin
condensation) were strongly increased when protein synthe-
sis was inhibited by CHX. This is most likely caused by the
inhibition of NF-κB mediated induction of survival and/or
antiapoptotic proteins [32]. In parallel necrosis markers
like LDH release and the detachment of HMGB1 from
chromatin were strongly enhanced. These phenomena are
most likely caused by post-apoptotic events or secondary
necrosis occurring at late time points after the onset of
apoptosis [33], which was initiated 24 hours prior to analysis
ofthecells.Thisissupportedbytheobservationthatcaspase-
3 activity in cells treated with the combination of TNFα and
CHX was similar to that of cells treated with TNFα only. It
is likely that the cells had already passed maximum apoptosis
and caspase-3 activity at this time point and went into post-
apoptotic necrosis.
CAPE has been described to inhibit the activation of
NF-κB and therefore it prevents the increased expression of
antiapoptoticproteins,whichexplainsantiinﬂammatoryand
proapoptotic eﬀects of CAPE [34–36]. Noteworthy, in our
analyses preincubation of TNFα-induced cells with CAPE
didnotleadtoincreasedapoptosisasmightbeexpected.This
is presumably due to the rather low concentrations (5μM) of
CAPEapplied,whichmightnothaveastrongenoughimpact
on regulation of antiapoptotic gene expression mediated
by NF-κB. Low concentrations of CAPE as used by others
[37, 38] were employed since higher amounts displayed
cytotoxicity in PCPEC (data not shown). Still, CAPE was8 Journal of Biomedicine and Biotechnology
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Figure 8: TNFα induces HMGB1 release as well as HBGB1 binding in PCPEC. TNFα-stimulated PCPEC loose membrane integrity. PCPEC
were stimulated with TNFα (100ng/mL) ± cycloheximide (CHX) (1μg/mL) for 10 hours. For a positive control PCPECs were treated
with staurosporine (1μM). (a) Adherent cells were labelled according to the Live/Dead assay protocol. Vital cells are penetrated by calcein
and show a green ﬂuorescence, damaged cells were penetrated by ethidium homodimer and show red ﬂuorescent nuclei. Images were
obtained by ﬂuorescence microscopy (400 × magniﬁcation) using a digital camera. (b) Chromatin of vital and apoptotic cells binds HMGB1
(red) whereas TNFα ± CHX and staurosporine stimulated PCPEC partly released HMGB1 from nuclei (i.e., post-apoptotic necrosis; white
arrows). DAPI staining revealed also that TNFα ± cycloheximide (CHX) resulted in chromatin condensation in PCPEC and binding of
HMGB1 (i.e., apoptosis; yellow arrows). Both were detected by ﬂuorescence microscopy (1000 × magniﬁcation) and photographs were
taken using a digital camera. The whole well was examined for each experimental condition in two separate experiments; results from one
representative experiment are shown.
added in active concentrations, because preincubation with
CAPE attenuated loss of barrier function caused by TNFα
or the combination of TNFα with CHX. TNFα was shown
to increase tight junction permeability via NF-κBa c t i v a t i o n
in brain microvascular endothelial cells and Caco2 intestinal
epithelial cells [37, 39]. In line with our experiments, in
the study by Ma and coworkers TNFα alone did not lead
to a substantial amount of apoptosis and cotreatment withJournal of Biomedicine and Biotechnology 9
NF-κB inhibitors prevented loss of barrier function [39].
CAPE has been shown to exhibit antioxidant, antiinﬂamma-
tory and immunomodulatory characteristics and can alter
the intracellular redox state [40]. Possibly, CAPE inhibits
additional downstream eﬀects of NF-κB, which are involved
in barrier breakdown. NF-κB independent properties of
CAPE may also be responsible for the observed eﬀects. Since
CAPE did not inhibit the apoptotic hallmarks caused at
low levels by TNFα and in higher amounts by TNFα in
combinationwithCHX,thesedownstreameﬀectsapparently
do not involve apoptotic phenomena.
The JNK-inhibitor SP600125 attenuated loss of TEER
caused by TNFα alone. We speculate that this eﬀect is due
to the inhibition of late proapoptotic functions mediated
by JNK after prolonged induction with TNFα [12, 41, 42].
Otherwise, we observed no signiﬁcant eﬀects of the JNK
inhibitor, indicating that JNK signalling plays a rather minor
role in TNFα mediated barrier breakdown.
In summary, our data point to a role of apoptotic
and necrotic phenomena as well as cell death independent
mechanisms during the loss of PCPEC barrier function
after treatment with TNFα, mediated via TNFR downstream
pathways involving activation of caspases and signaling by
NF-κB.
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